Arkolith/Insider Trading/GRNA/Form 4

Ortega-Valle Marta

Chief Business OfficerGreenLight Biosciences Holdings, PBC (GRNA) · full profile →Form 4 · filed Sep 7, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 1, 2022Option exercise(M)30K$0.23$7K30K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 1, 2022Option exercise(M)30K——0

Transaction Codes

M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001062993-22-019304) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML